Shelf life (days): 1460.0
Formulation: A solid
Formal Name: 2S-(methyl-d3)-butanoic acid-2,3,3,4,4,4-d6, 1S,2,3R,7S,8S,8aR-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
Purity: ≥99% deuterated forms (d1-d9)
Formula Markup: C24H27D9O5
Formula Weight: 413.59418
Notes: Lovastatin-d9 is intended for use as an internal standard for the quantification of lovastatin (Item No. 10010338) by GC- or LC-MS. Lovastatin is a fungal metabolite that has been found in A. terreus and an inhibitor of HMG-CoA reductase (Ki = 1.4 nM).{15081,15251} It is also a prodrug form of the HMG-CoA reductase inhibitor lovastatin hydroxy acid (Item No. 10010339).{15251} Lovastatin (8 mg/kg per day) reduces plasma cholesterol levels in dogs. It suppresses TNF-induced NF-κB activation (IC50 = ~15 µM) and potentiates apoptosis in human myeloid leukemia cells.{15363} Lovastatin also increases cellular lipid peroxidation and decreases glutathione peroxidase 4 (GPX4) levels in cancer cells.{43393} Formulations containing lovastatin have been used in the treatment of hypercholesterolemia.
Deutsch
English
